论文部分内容阅读
米非司酮配伍米索前列醇用于非肝病孕妇足月引产已有很多报道。但用于肝病孕妇是否安全,用药剂量和途径对孕妇及胎儿的安全性如何,是我们关心的问题。本研究对100例肝炎孕妇足月引产者用同等剂量米非司酮配伍米索前列醇同等剂量,对不同途径给药进行对比,以期寻求一种最佳方案,力求引产成功率提高,副作用减少。 1 资料与方法 1.1 观察对象及方法:1997年6月～1998年5月在我院分娩的单胎,头位初产妇100例、孕龄37
Mifepristone with misoprostol for non-liver disease in pregnant women have full-term abortion have been reported. But for the safety of liver disease pregnant women, medication dosage and route of safety for pregnant women and fetus, is our concern. In this study, 100 cases of pregnant women with full-term hepatitis induced pregnant women with the same dose of mifepristone with misoprostol equivalent dose compared to different routes of administration in order to find the best solution to improve the success rate of induced labor, reduce side effects . 1 Materials and Methods 1.1 Observation objects and methods: June 1997 ~ May 1998 in our hospital childbirth of a single birth, 100 cases of primipara, gestational age 37